DirectSync Surgical

Executive Summary

DirectSync Surgical is a San Diego-based pre-clinical medical device company developing smart implants that harness human motion to power implantable sensors and enhance bone healing without batteries or external stimulators. Founded in 2019, the company targets spine and orthopedic surgery, aiming to revolutionize patient monitoring and recovery. By converting kinetic energy from movement into electrical power, their implants can continuously collect physiological data while actively promoting osteogenesis, potentially reducing complications and improving outcomes. The technology addresses key limitations of current active implants, such as battery life and infection risks from transcutaneous wires. While still in early development and without disclosed funding rounds, DirectSync Surgical's novel approach positions it in the emerging field of self-powered bioelectronic medicine. The company's progress will depend on successful preclinical validation, regulatory pathway clarity, and ability to attract partnerships or financing for first-in-human studies.

Upcoming Catalysts (preview)

• Q1 2027Publication of preclinical efficacy data in animal models60% success
• Q2 2027FDA breakthrough device designation or pre-submission meeting40% success
• Q3 2027Series A funding round or strategic partnership50% success